Current Radiopharmaceuticals publishes original research articles, letters, reviews, drug clinical trial studies and guest edited issues on all aspects of research and development of radiolabelled compound preparations. The scope of the journal covers the following areas: radio imaging techniques, therapies; preparation and application of radionuclide compounds including the incorporation of tracer methods used in scientific research and applications.
Articles from the journal Current Radiopharmaceuticals 10, Issue 1:
- Radiopharmaceuticals for the Diagnosis and Therapy of Neuroendocrine Differentiated Prostate Cancer
- New Horizons on Molecular Pharmacology Applied to Drug Discovery: When Resonance Overcomes Radioligand Binding
- 177Lu-DOTA-Bevacizumab: Radioimmunotherapy Agent for Melanoma
- 99mTc-labeled White Blood Cell Scan as a Guide to Open Biopsy in the Management of Hip and Knee Prosthesis Infection: Preliminary Results
- Development of a Novel Carbon-11 Labeled PET Radioligand for Melanin- Concentrating Hormone Receptor 1
- Synthesis and Preliminary Evaluation of 5-[18F]fluoroleucine
- Development of a Radiolabeled Amlodipine Analog for L-type Calcium Channel Imaging
- A Sensitive Method for the Measurement of Copper at Trace Levels Using an HPLC-Based Assay
- Evaluation of the Influence of the Conjugation Site of the Chelator Agent HYNIC to GLP1 Antagonist Radiotracer for Insulinoma Diagnosis
For details on the articles, please visit this link :: http://bit.ly/2pBOwbj
Bentham Science 